NovoCure Ltd (NASDAQ:NVCR) shares, rose in value on Friday, March 28, with the stock price down by -0.58% to the previous day’s close as strong demand from buyers drove the stock to $18.86.
Actively observing the price movement in the last trading, the stock closed the session at $18.97, falling within a range of $18.405 and $18.93. The value of beta (5-year monthly) was 0.628. Referring to stock’s 52-week performance, its high was $34.13, and the low was $11.70. On the whole, NVCR has fluctuated by -1.92% over the past month.
With the market capitalization of NovoCure Ltd currently standing at about $2.07 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 613.71M, with a low estimate of 145M and a high estimate of 150.3M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 147.57M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that NVCR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of NVCR currently trading nearly -2.93% and -13.46% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.74, while the 7-day volatility ratio is showing 3.94% which for the 30-day chart, stands at 5.26%. Furthermore, NovoCure Ltd (NVCR)’s beta value is 0.63, and its average true range (ATR) is 0.96.
A comparison of NovoCure Ltd (NVCR) with its peers suggests the former has fared considerably weaker in the market. NVCR showed an intraday change of -0.58% in last session, and over the past year, it grew by 44.30%%.
Data on historical trading for NovoCure Ltd (NASDAQ:NVCR) indicates that the trading volumes over the past 10 days have averaged 0.65 and over the past 3 months, they’ve averaged 919.19K. According to company’s latest data on outstanding shares, there are 108.52 million shares outstanding.
Nearly 10.53% of NovoCure Ltd’s shares belong to company insiders and institutional investors own 83.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.4 million shares as on 2025-03-14, resulting in a short ratio of 4.8. According to the data, the short interest in NovoCure Ltd (NVCR) stood at 585.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 5.2 million. The stock has fallen by -36.71% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NVCR stock heading into the next quarter.
